title: [Acute hepatitis probably secondary to the treatment with pyrimethamine-sulfadiazine combination].
authors.forename: B
authors.initials: B
authors.lastname: Geier
authors.forename: J P
authors.initials: JP
authors.lastname: Nousbaum
authors.forename: J M
authors.initials: JM
authors.lastname: Cauvin
authors.forename: M
authors.initials: M
authors.lastname: Rosaszkiewick
authors.forename: H
authors.initials: H
authors.lastname: Gouérou
mesh_terms: D000208:Acute Disease; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D013411:Sulfadiazine / Q000009:adverse effects* / Q000627:therapeutic use; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy
chemical_list: D013411:Sulfadiazine; D011739:Pyrimethamine
vernacular_title: Atteinte hépatique aiguë probablement secondaire à un traitement par l'association pyrrméthamine-sulfadiazine.